Why the study?
Does fondaparinux prevent venous thromboembolic events in older acute medical patients?
Population
older acute medical patients
Comparison
fondaparinux vs placebo
Design
RCT, randomised, placebo controlled
Authors
Loading...
Supports fondaparinux for VTE prophylaxis in older acute medical patients; confirms efficacy without increased major bleeding.
Does fondaparinux prevent venous thromboembolic events in older acute medical patients?
Fondaparinux effectively prevents venous thromboembolism in older acute medical patients without increasing major bleeding compared to placebo.
Cohen et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: